Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 06, 2026 16:01 ET | Source: Ocular Therapeutix, Inc. BEDFORD, Mass.,…
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 06, 2026 16:01 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The…
Ferrero Group reports Consolidated Financial Statements for the 2024/2025 Financial Year
Ferrero Group maintains its growth trajectory with a 4.6% increase in turnover…
Hexaware Reports CY25 Revenue of USD 1,537.4 Mn, Marking 7.6% YoY Growth Q4CY25 Revenue at USD 389 Mn, Up 4.5% YoY, EBITDA Expands by 65 bps YoY
MUMBAI, India, Feb. 4, 2026 /PRNewswire/ -- Hexaware Technologies (NSE: HEXT), a…
Star Health reports 414% YoY Ind AS Profit growth to 449 Cr for Q3 FY26
Q3 Combined Ratio improves 317 bps to 98.9% driven by Loss Ratio…
Yutong Bus Reports Continued Sales Growth in 2025, Advancing Sustainable Public Transportation Worldwide
Steady operating performance, innovation-driven growth, and ESG integration reinforce long-term value creationZHENGZHOU,…
REALTY ONE GROUP CELEBRATES 20 YEARS OF COMMUNITY IMPACT, REPORTS STRONG 2025 GIVING RESULTS
LAGUNA NIGUEL, Calif., Jan. 26, 2026 /PRNewswire/ -- Realty ONE Group International,…
Premier Health Reports 2025 Fourth Quarter Results
MONTRÉAL, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Premier Health of America Inc.…
CORRECTING and REPLACING — BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
January 27, 2026 17:10 ET | Source: BridgeBio Pharma, Inc. PALO ALTO,…
STL reports Q3 FY’26 results; strengthens technology leadership
MUMBAI, India, Jan. 23, 2026 /PRNewswire/ -- STL (NSE: STLTECH), a leading…
